Conscience May 2026 Policy Brief - Federal Action to Accelerate Psychedelic Treatments for Serious Mental Illness
Zenodo (CERN European Organization for Nuclear Research) May 26, 2026 DOI: 10.5281/zenodo.20402457 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Keywords | Mental illness Pace Action physics Mental health Executive order Conscience Order exchange Government linguistics Criminology Public policy Mentally ill Culpability |
| Key points | The executive order aims to accelerate psychedelic treatments for serious mental illness by granting priority review vouchers and addressing regulatory barriers. |
Abstract
Federal Action to Accelerate Psychedelic Treatments for Serious Mental Illness President Trump signed an executive order (the “Order”), on April 18th 2026, titled “Accelerating Medical Treatments for Serious Mental Illness”. The Order addresses the slow pace of development and limited availability of psychedelic treatments for serious mental health conditions. This represents a major shift in federal policy as psychedelic drug research has historically been limited by regulatory barriers, especially restrictions connected to Schedule I controlled substances. This policy introduces the purpose of the executive order, the granting of priority review vouchers, and potential lessions learned.